Category: Off-label Promotion

CHC_FDA-Regulatory Images1

10/19/2018

Bad Ad Program Yields Two OPDP Enforcement Letters on Risk, Safety Information

CHC_Legislative1

01/22/2018

House Bill on Sharing Certain Information about Investigational Products Moves Forward

CHC_offLabel

07/14/2017

House Subcommittee Considers Two Off-label Bills

slide_offLabel2

05/30/2017

Response to Califf’s Call for Off-label Code of Ethics Is on Industry’s Radar

05/18/2017

Califf Calls for Off-label Promotion Code of Ethics

CHC_offLabel

02/24/2017

Citizen Petition Calls on FDA to Stay Final Rule Establishing “Totality of the Evidence” Standard for Intended Use

CHC_firstamendment1

01/20/2017

New Memorandum Spells Out FDA’s First Amendment Position on Off-label Use Promotion

CHC_offLabel

12/15/2016

FDA Extending Unapproved Use Communications Comment Period

CHC_offLabel

11/10/2016

Speakers at FDA Off-label Hearing Call for Action that Protects Free Speech